(Q39450052)

12 September 2017

title

Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells (English)

1 reference

12 September 2017

0 references

0 references

Yangle Li

1

1 reference

12 September 2017

Xiaokun Zhao

2

1 reference

12 September 2017

Huiting Tang

3

1 reference

12 September 2017

Zhaohui Zhong

4

1 reference

12 September 2017

Lei Zhang

5

1 reference

12 September 2017

Ran Xu

6

1 reference

12 September 2017

Songchao Li

7

1 reference

12 September 2017

Yi Wang

8

1 reference

12 September 2017

publication date

25 October 2011

1 reference

12 September 2017

published in

Urologia Internationalis

1 reference

12 September 2017

volume

88

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

95-101

1 reference

Bladder cancer clinical trials

12 September 2017

cites work

1 reference

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

The magic of the hypoxia-signaling cascade

21 January 2018

1 reference

HIF gene expression in cancer therapy

21 January 2018

1 reference

Hypoxia-inducible factor 1 and cancer pathogenesis

21 January 2018

1 reference

Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer

21 January 2018

1 reference

Evaluation of relationship between HIF-1alpha immunoreactivity and stage, grade, angiogenic profile and proliferative index in bladder urothelial carcinomas

21 January 2018

1 reference

New anticancer strategies targeting HIF-1.

21 January 2018

1 reference

Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells.

21 January 2018

1 reference

HIF-1 as a target for drug development

21 January 2018

1 reference

YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.

21 January 2018

1 reference

Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2).

21 January 2018

1 reference

A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}.

21 January 2018

1 reference

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

21 January 2018

1 reference

YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

21 January 2018

1 reference

Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells

21 January 2018

1 reference

Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells

21 January 2018

1 reference

Structural and functional analysis of hypoxia-inducible factor 1.

21 January 2018

1 reference

Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226.

21 January 2018

1 reference

Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK.

21 January 2018

1 reference

A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000331881

1 reference

12 September 2017

1 reference